« iepriekšējāTurpināt »
ORGANIZATIONS REPRESENTED AT HEARINGS
American Civil Liberties Union, Lawrence Speiser, director, Washington (D.C.) Office.
American College of Neuro-Psycho Pharmacology, Dr. Jonathan O. Cole. American Medical Association:
Brill, Dr. Henry, chairman, Committee on Alcoholism and Drug Dependence, Council on Mental Health. Peterson, Harry N., attorney, Legislative Department.
American Pharmaceutical Association:
Apple, Dr. William S., executive director.
Roberts, Carl, director, Legal Division.
American Psychiatric Association:
Freedman, Dr. Daniel X., professor and chairman, Department of
West, Dr. Louis Jolyon, trustee.
American Public Health Association, Dr. James L. Goddard.
Committee for Effective Drug Abuse Legislation, Dr. Jonathan O. Cole, chairman.
Council of Health Organizations, Dr. Paul Lowinger.
Health, Education, and Welfare Department:
Dobbs, Dr. Dorothy, Director, Marketed Drugs Division, Bureau of
Gibson, Dr. Merle, Director, New Drugs Division, Bureau of Drugs,
Goodrich, William, General Counsel, Bureau of Drugs, Food and Drug
Jennings, Dr. John, Acting Director, Bureau of Drugs, Food and
Miller, Dr. Morton G., Associate Director for Special and Collabora-
Yolles, Dr. Stanley F., Director, National Institute of Mental Health. Justice Department:
Mitchell, Hon. John N., Attorney General.
Dean, John W., III, Associate Deputy General.
Ingersoll, John E., Director, Bureau of Narcotics and Dangerous
Lewis, Dr. Edward, Chief Medical Officer, Bureau of Narcotics and
Sonnenreich, Michael R., Deputy Chief Counsel, Bureau of Narcotics
National Association for Mental Health, Inc.:
Freeland, Michael E., associate director.
Wright, Mrs. J. Skelly, secretary.
National Association of Boards of Pharmacy, Fred T. Mahaffey, executive director.
National Association of Retail Druggists, William E. Woods, Washington representative.
National Association of State Mental Health Program Directors:
Farabee, Dr. Dale, secretary.
Schnibbe, Harry C., executive director.
Pharmaceutical Manufacturers Association:
Brennan, Bruce J., vice president and general counsel.
Patton, William D., assistant general counsel.
Stoddard, Ezekial G., special counsel.
Smith Kline & French Laboratories:
David, Clifford C., legislative counsel.
Fletcher, Donald K., Manager of Distribution Protection.
DRUG ABUSE CONTROL AMENDMENTS-1970
TUESDAY, FEBRUARY 3, 1970
HOUSE OF REPRESENTATIVES,
SUBCOMMITTEE ON PUBLIC HEALTH AND WELFARE,
COMMITTEE ON INTERSTATE AND FOREIGN COMMERCE, Washington, D.C. The subcommittee met, pursuant to notice, at 10 a.m., in room 2322, Rayburn House Office Building, Hon. John Jarman (chairman of the subcommittee) presiding.
Mr. JARMAN. The subcommittee will please be in order.
The hearings today are on numerous bills pending before the committee dealing with the overall subject of drug abuse.
The bills represent a variety of approaches. In general, they provide for increased research and training of personnel to deal with drug abuse problems; with increased educational and informational efforts to attempt to prevent drug abuse; with providing facilities for the care and rehabilitation of drug abusers; and with revision of existing restrictions on distribution of drugs subject to abuse.
Last year the administration submitted comprehensive recommendations, designed generally to consolidate all Federal laws relating to drug abuse into one statute. Since the bill as recommended fell within the jurisdiction of both this committee and the Committee on Ways and Means, the bill was redrafted so that the provisions relating to drugs over which this committee has jurisdiction were incorporated in one measure, and the provisions relating to marihuana and the so-called hard narcotics were included in another bill-H.R. 13742—which is presently pending before the Ways and Means Committee.
The purpose of these hearings will be to explore the various alternatives pending before this committee designed to deal with the serious public health problem of drug abuse.
(The text of H.R. 11701, H.R. 13743, H.R. 9158, H.R. 10342, H.R. 10408, H.R. 12882, H.R. 12894, H.R. 13031, H.R. 13092, H.R. 13136, H.R. 13460, H.R. 13498, H.R. 13561, H.R. 13785, H.R. 14376, H.R. 14479, H.R. 14480, H.R. 14774, H.R. 15432, and H.R. 15501, and departmental reports thereon follow :)
[H.R. 11701, 91st Cong., 1st sess., introduced by Mr. Staggers on May 27, 1969] A BILL To amend the Public Health Service Act, the Federal Food, Drug, and Cosmetic Act, the Community Mental Health Centers Act, and other acts to establish a comprehensive program to deal with narcotic addiction and drug abuse, to provide for control of marihuana, and for other purposes
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. This act may be cited as the "Comprehensive Drug Abuse Control Act of 1969."
PROGRAMS UNDER COMMUNITY MENTAL HEALTH CENTERS ACT RELATING TO DRUG ABUSE AND ADDICTION
SEC. 2. (a) Section 252 of the Community Mental Health Centers Act is amended to read as follows:
TRAINING AND EVALUATION
"SEC. 252. (a) For the purpose of assisting in overcoming the critical shortage of scientific and professional personnel trained to deal with drug abuse and addiction, the Secretary is authorized to make grants to States and political subdivisions thereof and to public or nonprofit private agencies and organizations, and to enter into contracts with other private agencies and organizations, for"(1) the development of specialized training programs or materials relating to the provision of health services for the prevention and treatment of drug abuse;
"(2) the development of inservice or short-term refresher courses with respect to the provision of such services;
(3) training personnel to operate, supervise, and administer such services;
"(4) the conduct of a program of research and study relating to (A) personnel practices and current and projected personnel needs in the field of drug abuse (including prevention, control, treatment, and rehabilitation), (B) the availability and adequacy of the educational and training resources of individuals in, or preparing to enter, such field, and (C) the availability and adequacy of specialized training for persons such as physicians and other health professionals who have occasion to deal with drug addicts, including the extent to which such persons make the best use of their professional qualifications when dealing with such persons; and
"(5) the conduct of surveys and field trials to evaluate the adequacy of the programs for the prevention and treatment of narcotic addiction within the several States with a view to determining ways and means of improving, extending, and expanding such programs.
"(b) As used in this section, the term 'professional personnel' includes persons in the fields of medicine, psychiatry, nursing, social work, psychology, education, and vocational rehabilitation."
(b) The Community Mental Health Centers Act is amended by redesignating sections 253 and 254 as sections 255 and 256, respectively, and by inserting after section 252 the following new sections:
"SEC. 253. (a) The Secretary is authorized to make fellowship grants (including such stipends and allowances (including travel and subsistence expenses) as the Secretary may deem necessary) to professional personnel for training in relation to drug addiction and other drug-abuse-related problems. Each applicant for a fellowship grant shall present a plan for his training which includes appropriate information regarding the participation of the institutions or agencies who will be providing the training.
"(b) As used in this section, the term 'professional personnel' includes persons in the fields of medicine, psychiatry, nursing, social work, psychology, education, and vocational rehabilitation.
"DRUG ABUSE EDUCATION
"SEC. 254. (a) The Secretary is authorized to make grants to States and political subdivisions thereof and to public or nonprofit private agencies and organizations, and to enter into contracts with other private agencies and organizations, for— "(1) the collection, preparation, and dissemination of educational materials dealing with the use and abuse of drugs and the prevention of drug abuse, and
"(2) the development and evaluation of programs of drug abuse education directed at the general public, school-age children, and special high-risk groups.
(b) The Secretary, acting through the National Institute of Mental Health, shall (1) serve as a focal point for the collection and dissemination of information related to drug abuse; (2) collect, prepare, and disseminate materials (in
cluding films and other educational devices) dealing with the abuse of drugs and the prevention of drug abuse; (3) provide for the preparation, production, and conduct of programs of public education (including those using films and other educational devices); (4) train professional and other persons to organize and participate in programs of public education in relation to drug abuse; (5) coordinate activities carried on by such departments, agencies, and instrumentalities of the Federal Government as he shall designate with respect to health education aspects of drug abuse; (6) provide technical assistance to State and local health and educational agencies with respect to the establishment and implementation of programs and procedures for public education on drug abuse; and (7) undertake other activities essential to a national program for drug abuse education.
"(c) The Secretary, acting through the National Institute of Mental Health, is authorized to develop and conduct workshops, institutes, and other activities for the training of professional and other personnel to work in the area of drug abuse education."
(c) Section 261 of the Community Mental Health Centers Act is amended(1) by striking out "for the next fiscal year" in the first sentence of subsection (a) and inserting in lieu thereof "for each of the next four fiscal years";
(2) by striking out "and for grants under section 252" in the first sentence of subsection (a);
(3) by striking out "each of the next three fiscal years" in subsection (b) and inserting in lieu thereof "each of the next seven fiscal years"; and
(4) by striking out "for which a staffing grant was made from appropriations under subsection (a) of this section for the fiscal year ending June 30, 1969, or the fiscal year ending June 30, 1970" in subsection (b) and inserting in lieu thereof the following: "(1) for which a staffing grant was previously made from appropriations under subsection (a) of this section, and (2) which is eligible for such a grant for the fiscal year for which sums are appropriated under this subsection".
RESEARCH UNDER THE PUBLIC HEALTH SERVICE ACT IN DRUG USE, ABUSE, AND ADDICTION SEC. 3. (a) Section 303 (a) of the Public Health Service Act (42 U.S.C. 252a (a)) is amended by striking out the period at the end of paragraph (2) and by adding after that paragraph the following:
"(3) to support and conduct programs of research into all phases of drug use and abuse, including the origins, causes, incidence, and prevention of drug use and abuse, the abuse potential of drugs, and the therapeutic and rehabilitation agents and techniques;
"(4) to make grants to State or local agencies and other public or nonprofit agencies and institutions, and to enter into contracts with any other agencies or institutions, for the conduct of investigations, experiments, demonstrations, studies, and research projects with respect to the development of improved methods of diagnosing drug addiction and abuse and of care, treatment, and rehabilitation of drug addicts and drug abusers;
"(5) to make grants to State agencies responsible for administration of State institutions for care, or care and treatment, of drug addicts or abusers for developing and establishing improved methods of operation and administration of such institutions;
"(6) to conduct surveys evaluating the adequacy of programs for the prevention and treatment of drug abuse and for necessary planning studies; "(7) to develop field trials and demonstration programs for the prevention and treatment of drug abuse;
"(8) to establish a National Registry of Narcotic Addicts to facilitate research in drug addiction; and
"(9) to make project grants to State or local agencies and other public or nonprofit agencies or institutions for the establishment, construction, staffing, operation, and maintenance of regional centers for research in drug abuse and related problems, one of which centers shall be established as a National Addiction and Drug Abuse Research Center as part of the National Institute of Mental Health, and shall be located in close proximity to the central research facilities of such Institute so as to avoid duplication of basic science laboratories and to allow for exchange of scientific information in collaboration between researchers in these closely related areas.